Monoclonal antibodies were raised against homogeneous Ro and La antigens, two proteins associated with Ro and La ribonucleoproteins (RNPs). The specificity of the monoclonal antibodies was proven by immunoblot analysis and by immunoprecipitation. The anti-Ro antibody reacted with a Mr 95,000 protein in a mouse lymphoma cell extract and with a Mr 60,000 polypeptide in extracts from human spleen. The anti-La antibody recognized a Mr 50,000 polypeptide in the mouse L5178y cell extract. (3, 4) . RNA analysis revealed that Ro small cytoplasmic RNPs (scRNPs) carry the La as well as the Ro determinants and, consequently, were a subclass of La RNPs (5). Based on immunoprecipitation studies, the molecular weight of the Ro antigen(s) was determined to be 94,000 (90,000) (6), while analysis by immunoblotting revealed a Mr of 57,000 (7). Comparative experiments using the techniques of counterimmunoelectrophoresis and immunoblotting led to the assumption that the Ro antigenic determinant is labile when exposed to NaDodSO4 (8 (Junction City, OR).
precipitated RNPs that contained the typical RNA species of Ro or La RNPs. The localization of Ro and La antigen was performed by direct immunofluorescence microscopy. It was found that the anti-Ro antibody reacted with a fibrous network that behaves like cytokeratin, one of the intermediate filament systems. The anti-La antibody reacted with nuclear structures that gave a speckled-type pattern.
Four different major types of autoantibodies to ribonucleoproteins (RNPs) have been identified in patients with various rheumatic diseases: anti-Ul RNP, anti-Sm, anti-Ro, and anti-La antibodies (1) . Several studies indicate that these patients often produce a set of antibodies recognizing different epitopes on RNPs (reviewed in ref.
2)-e.g., anti-Ro antibodies are mostly accompanied with anti-La antibodies (3, 4) . RNA analysis revealed that Ro small cytoplasmic RNPs (scRNPs) carry the La as well as the Ro determinants and, consequently, were a subclass of La RNPs (5) . Based on immunoprecipitation studies, the molecular weight of the Ro antigen(s) was determined to be 94,000 (90,000) (6) , while analysis by immunoblotting revealed a Mr of 57,000 (7) . Comparative experiments using the techniques of counterimmunoelectrophoresis and immunoblotting led to the assumption that the Ro antigenic determinant is labile when exposed to NaDodSO4 (8) . Recently we succeeded in the purification of the Ro antigen, characterized by a Mr of 94,000. Moreover, this protein was identified in the RNP particle exhibiting endoribonuclease VII activity (ref. 9 ; unpublished data). It is generally agreed that the molecular weight of the La protein is around 50,000 (2, 7). Anti-Ro antibodies were determined to immunoprecipitate five small RNAs from human cells termed hYl-5 (hY2 is processed from hYl) (10), while anti-La antibodies immunoprecipitate a highly banded spectrum of small RNAs (11) .
Here we report a more extensive characterization of the Ro and La antigens by means of monoclonal antibodies (mAbs) raised against them. We show that the Ro antigen is associated with cytokeratin, while the La antigen primarily resides in the nucleus. Preparation of the Anti-Ro and Anti-La mAbs. Homogeneous Ro and La antigens were prepared from L5178y mouse lymphoma cells (38) . Briefly, crude cell extracts were enriched for Ro and La antigens by ammonium sulfate fractionation (45-80% saturation), ribonuclease A treatment, and Sephadex G-150 gel filtration. This extract was further purified by immunoaffinity column chromatography with monospecific antibodies against the Ro and La antigens according to the procedure described below for the application of mAbs. The antisera were obtained from patients with autoimmune disorders. The homogeneity of the antigen preparations was proven by NaDodSO4/gel electrophoresis, and their specificities, by immunoblotting (12) with standardized reference antisera (anti-Ro and anti-La; Centers for Disease Control, Atlanta). General procedures for preparation of mAbs (12, 13) (12) . In a further step, the antibodies were purified by immunoaffinity column chromatography using normal anti-mouse IgG coupled to Sepharose 4B (14) . The purification procedure was given earlier (14 *To whom reprint requests should be addressed.
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Proc. Natl. Acad. Sci. USA 83 (1986) 7771 test procedure using class-specific goat anti-mouse antibodies (Medac, Hamburg, F.R.G.).
Isolation of the La and Ro Antigen by Immunoaffinity Chromatography. L5178y mouse lymphoma cells (5 x 109) were harvested from the ascites of 12 mice and collected by centrifugation (1000 x g for 10 min at 40C). The cells were washed with buffer A (10 mM Tris HCl, pH 7.4/150 mM NaCl) and resuspended in 60 ml ofbuffer A and homogenized for 5 min by an Ultra Turrax (Janke-Kunkel, Staufen, F.R.G.). Subsequently, the homogenate was sonicated and centrifuged (15) . The supernatant (crude extract) was brought to 45% saturation with (NH4)2SO4. After centrifugation (12 ,000 x g for 15 min at 40C), (NH4)2SO4 was added to the supernatant to a final concentration of 80%. The precipitate formed was collected by centrifugation, dissolved in 20 ml of buffer A, and dialyzed against the same buffer. During dialysis, the fraction was treated with insoluble ribonuclease A (10 units) and deoxyribonuclease I (250 Ag/ml) in the presence of protease inhibitors (leupeptin, chymostatin, and pepstatin, each at 5 Ag/ml, and 0.5 mM phenylmethylsulfonyl chloride). Then the fraction was passed through a Sephadex G-150 column (4 x 30 cm); the antigen-containing fractions, which were eluted in a Ve/VO range (16) between 1.3 and 1.9, were collected (260 ml) and concentrated by (NH4)2SO4 precipitation (80o saturation).
The pellet (enriched antigen fraction) was dissolved in 40 ml of buffer A and subjected to immunoaffinity chromatography on mAb-conjugated Sepharose. The mAbs were coupled to CNBr-activated Sepharose 4B (10 mg of the respective mAbs per 2 ml of Sepharose 4B; ref. 17 ). The antigencontaining fraction was passed through the anti-La mAbSepharose column. The flow-through fraction was loaded again on this column. The washing procedure with buffer A was continued until the fractions were negative for La antigen in the enzyme-linked immunosorbent assay (12) . For this procedure, 200 ,ul of the respective fraction was added to a well. After washing with phosphate-buffered saline (39), 1 ,ug of purified anti-La mAb was added per well, and the reaction was monitored with anti-mouse IgG peroxidase conjugate. The flow-through fraction was applied to the 2-ml anti-Ro mAb-Sepharose column and washed with 4 column volumes of buffer A. The La or Ro antigens were eluted from the corresponding mAb-Sepharose column with buffer B (200 mM glycine'HCl, pH 3.0/500 mM NaCl). The purified fractions were dialyzed against buffer A, lyophilized, and redissolved in buffer A at 1 mg/ml. To remove stable La/Ro complexes from free La antigen, the La eluate was passed again through the anti-Ro mAb-Sepharose column. The flow-through fractions were found to be negative for Ro antigen in the enzyme-linked immunosorbent assay. The obtained Ro and La antigens were assayed by immunoblotting (18) with standardized antisera from the Centers for Disease Control. The antigens were determined to be positive with the respective antisera. NaDodSO4/Polyacrylamide Gel-Nitrocellulose Sheet-Blotting Technique. Polyacrylamide (6%) gel electrophoresis in the presence of 0.1% NaDodSO4 was performed by the system of Laemmli (19) ; the gels were stained with silver (20) . Immunoblotting was performed as described (21) . Briefly, after the electrophoretic transfer of the proteins, the nitrocellulose sheet (BA 85; Schleicher & Schuill, no. 401180) was incubated first for 4 hr in blocking solution (buffer A containing 1% bovine serum albumin) and second for 2 hr in buffer A containing 100 ,ug of a serum from a nonimmunized animal per ml. After the sheets were washed with buffer A, they were incubated (30 min) with the respective mAbs at 15 ,ug/ml in buffer A (supplemented with 0.1% bovine serum albumin) and subsequently washed with buffer A (supplemented with 0.5% Tween 20). The bound antibodies were detected by reaction with peroxidase-labeled rabbit antimouse IgG, followed by incubation with 4-chloro-1-naphthol (12) .
For these experiments, crude extracts from L5178y cells (see above) or human spleen were used; they were prepared as described (22) .
Immunoprecipitation and RNA Analysis. Ten milliliters of a human spleen extract, isolated as described by Mattioli and Reichlin (22) (protein concentration, 10 mg/ml), was incubated (15 min at 370C) with 500 ,g of anti-Ro or anti-La mAb. The formed immunocomplexes were isolated by affinity chromatography on protein A-Sepharose (23). RNA was isolated from these complexes and fractionated on onedimensional polyacrylamide gels as described (15) .
Labeling of Antibodies. mAbs against the Ro and La antigen were conjugated with fluorescein isothiocyanate (FITC), whereas mAbs to cytokeratin and mAbs to a tubulin were labeled with rhodamine isothiocyanate (RITC) as described (24 (26) .
RESULTS
Characterization of the mAbs Against the Ro and La
Antigen. BALB/c mice were immunized with homogeneous Ro or La antigen to obtain mAbs directed against these proteins. Two hybridoma clones, one producing anti-Ro antibodies (Ro2F4) and a second one secreting anti-La antibodies (LalB5), were selected. Both types of mAbs belong to the IgG class. Immunoprecipitation experiments were performed to define the mAbs as anti-Ro or anti-La (Fig. 2A) . The anti-Ro mAb was shown to react with RNPs containing the four major RNA species, designated hY1 and hY3-hY5 (lane a). This RNA pattern has been shown to be typical for human Ro scRNPs (2, 5 (Fig. 1) (Fig. 3) . To determine whether the fine network of fibers, visualized by present in the crude extract from L5178y cells (Fig. 1) . Usually, anti-Ro mAbs have been determined to bind to a Mr 60,000 protein (reviewed in ref.
2). Therefore, we performed comparative studies (Fig. 2B) and could demonstrate that Proc. Natl. Acad. Sci. USA 83 (1986) FITC-labeled anti-Ro mAb, has similarities to one of the three major fibrous structures in animal cells, we performed double direct immunofluorescence studies with RITC-labeled anti-a tubulin (staining of microtubules), RITC-labeled phalloidin (staining of microfilaments), or RITC-labeled anticytokeratin (staining of intermediate filaments). Observations by this technique revealed that the pattern obtained with anti-Ro mAb is not identical with that network reacting with phalloidin ( Fig. 3 a and b) or with anti-a tubulin antibodies (Fig. 3 c and d) . However, an obviously complete superposition of the labeling pattern is obtained with anticytokeratin and anti-Ro antibodies (Fig. 3 e and ) .
In contrast to the Ro antigen, the La antigen was localized predominantly in the nucleus (Fig. 4 a and b) . The pattern is of the speckled type. DISCUSSION Ro and La proteins are known to be prone to partial proteolysis in crude tissue extracts (7) . In the present study we used mAbs directed against the Ro and La proteins to determine the molecular weight of these antigens in different tissues by immunoblotting. The anti-La mAb identified a single Mr 50,000 immunoreactive polypeptide in a crude extract from L5178y mouse cells; this finding is in agreement with other studies (2) . The anti-Ro antibody recognized two proteins of Mr 95,000 and Mr 90,000 in this extract. Comparative studies revealed that this anti-Ro antibody reacted predominantly with a Mr 60,000 polypeptide in a human spleen extract. The latter finding is in accordance with other reports (2) . The reason for the discrepancy in the molecular weight of the Ro antigen in the different tissues is unknown. One explanation may be that the Mr 60,000 polypeptide results from proteolytic degradation or is a processed form of the Mr 95,000 protein (that is also visible in the blot from human spleen extract; see Fig. 2B , lane c) as suggested earlier (7) . The specificity of the anti-Ro and anti-La mAbs was additionally established by immunoprecipitation experiments. It was found that anti-La and anti-Ro mAbs reacted with distinct RNP particles comprising the respective typical RNA species (2, 5, 10, 11) .
We used the defined mAbs for an analysis of the intracellular distribution of La and Ro antigen in the human epithelioma cell line HEp-2. By imnmunofluorescence it was shown that the anti-La mAb gave a characteristic speckled nuclear fluorescence (27) and little cytoplasmic staining. At present it is unknown with which supramolecular structures the La antigen, characteristically described as nuclear antigen (5, 28, 29) , is associated. It might be interesting that a similar speckled intranuclear pattern has been obtained by Chaly et al. (30) , using a mAb produced against isolated nuclear matrices, and by van Venrooij and his colleagues (31), using sera from patients with mixed connective tissue disease.
The Ro antigen is localized in the cytoplasm and found to be associated with one of the three major cytoskeletal elements, the intermediate filaments. By using the technique of double immunofluorescence staining, mAbs to the Ro antigen and to cytokeratin stained the same filamentous system in the cytoplasm of HEp-2 cells. In preliminary experiments, it was found that in other cell types not containing cytokeratin, other intermediate filament systems are stained with mAbs to the Ro antigen (unpublished data). No significant superposition of the patterns obtained with anti-Ro and anti-tubulin or rhodamine-phalloidin (which stains actin; ref. 32) was obtained.
The biological function of the Ro scRNPs remains to be discovered. It had been speculated that they participate in translation-related events (33)-perhaps in selection of distinct subsets of mRNAs abundant in brain and heart (4) . Thus, the presented finding that the Ro antigen is associated with cytokeratin filaments corroborates the intriguing possibility that binding of mRNA to this cytoskeletal element might be required for translation (34) (35) (36) 
